Trial Activation: CXC2 phase III study
Published:Category: Trials
The CXC2 (NCT02466971) trial: A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer has been centrally activated.
Read More
Dr. Elizabeth Eisenhauer Early Drug Development Young Investigator Award
Published:Category: News
Congratulations to the 2021 Winners Dr. Michael Ong and Dr. Albiruni Abdul Razak announced at the CCTG Spring Meeting last week. The Elizabeth Eisenhauer Young Investigator Award is presented to any MD, fellow, or PhD, within 7 years of certification / first faculty appointment, or current fellow who has either spent time at CCTG Central Office, worked on projects with the Investigational New Drug (IND) Program or who has contributed significantly to the conduct of an IND trial at a participating centre.
Read MoreDr. Ralph Meyer Phase III Young Investigator Award
Published:Category: News
Dr. Ralph Meyer Phase III Young Investigator Award
Congratulations from everyone at CCTG, The Ralph Meyer Young Investigator Award was presented to Dr Prica at the Annual Spring Meeting last week. The award hours MD, fellow, PhD within 10 years of certification / first faculty appointment or current fellow who has either spent time at CCTG Central Office, worked on Phase III projects with Disease Site Committees / Endpoint Committees / Working Groups, or who has contributed significantly to the conduct of a Phase III trial at a centre.
Read MoreDr. Joseph Pater Excellence in Clinical Trials Research Award
Published:Category: News
CCTG is proud to announce that the 2021 Founders Award was presented to Dr. Michael Crump this past weekend at the CCTG Spring Meeting. The Founder's Award is presented annually to an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer. This award honours an Investigator whose excellence in clinical trials research has provided techniques, information or concepts that will direct the future of the oncology research community and CCTG.
Read MorePhase III and IND Team Award Winners 2021
Published:Category: News
Congratulations to these trial teams and their member centres for their efforts and dedication to the success of CCTG clinical trials, these recipients were announced at the 2021 CCTG Annual Spring Meeting of Participants last week.
Read MorePublications: ME10, BRC5 and REC3
Published:Category: Publications
Primary Publications added to the CCTG database for: ME10, BRC5 and REC3 Read More
Journal Publications
Published:Category: Publications
Two publications: Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value Framework and Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials Read More
CCTG Spring meeting 2021 Update
Published:Category: Group updates
The #CCTG2021 Virtual Spring Meeting is less than a month away!
The first round of invitations has been sent so check your inbox for your invitation email. If you cannot find your e-invitation in your inbox, please check your trash or spam folders. If you need to have your e-invitation re-sent please e-mail us at meeting.spring@ctg.queensu.ca.
Read More